BE890209A - Compose de coordination du platine - Google Patents
Compose de coordination du platine Download PDFInfo
- Publication number
- BE890209A BE890209A BE0/205862A BE205862A BE890209A BE 890209 A BE890209 A BE 890209A BE 0/205862 A BE0/205862 A BE 0/205862A BE 205862 A BE205862 A BE 205862A BE 890209 A BE890209 A BE 890209A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- coordination compound
- platinum coordination
- compound
- adduct
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title description 11
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title description 9
- 229910052697 platinum Inorganic materials 0.000 title description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- -1 aliphatic amines Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 238000002411 thermogravimetry Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8028484 | 1980-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE890209A true BE890209A (fr) | 1982-01-04 |
Family
ID=10515824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/205862A BE890209A (fr) | 1980-09-03 | 1981-09-03 | Compose de coordination du platine |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5777694A (cs) |
| KR (1) | KR890000640B1 (cs) |
| BE (1) | BE890209A (cs) |
| SU (2) | SU1256698A3 (cs) |
| ZA (1) | ZA815852B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA843515B (en) * | 1983-05-10 | 1985-01-30 | Andrulis Res Corp | Bis-platinum complexes as antitumor agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1578323A (en) * | 1976-02-26 | 1980-11-05 | Rustenburg Platinum Mines Ltd | Compositions containing platinum |
-
1981
- 1981-08-25 ZA ZA815852A patent/ZA815852B/xx unknown
- 1981-09-02 KR KR1019810003274A patent/KR890000640B1/ko not_active Expired
- 1981-09-03 JP JP56137856A patent/JPS5777694A/ja active Granted
- 1981-09-03 BE BE0/205862A patent/BE890209A/fr not_active IP Right Cessation
-
1982
- 1982-05-03 SU SU823434800A patent/SU1256698A3/ru active
- 1982-09-20 SU SU3495252A patent/SU1188179A1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| SU1188179A1 (ru) | 1985-10-30 |
| KR890000640B1 (ko) | 1989-03-22 |
| ZA815852B (en) | 1982-08-25 |
| KR830008543A (ko) | 1983-12-10 |
| JPH0349916B2 (cs) | 1991-07-31 |
| SU1256698A3 (ru) | 1986-09-07 |
| JPS5777694A (en) | 1982-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI87792B (fi) | Tigogenin-cellubiosid-okta-acetat | |
| FR2489314A1 (fr) | Compose de coodination du platine | |
| FR2421884A1 (fr) | Procede de preparation de maleimides substitues a l'azote | |
| US5399757A (en) | Process for the preparation of N-(4-hydroxyphenyl)-retinamide | |
| US4705869A (en) | Preparation of fatty acid esters of ascorbic acid | |
| US4699925A (en) | Biphenylylpropionic acid derivative and pharmaceutical composition containing the same | |
| BE890209A (fr) | Compose de coordination du platine | |
| US4218446A (en) | Substituted steroid-spiro-oxazolidinone derivatives and a process for the preparation thereof | |
| Herkes et al. | Mono-and disubstituted vinyltrialkylammonium compounds. Synthesis and stereochemistry | |
| CH621127A5 (cs) | ||
| KR950006866B1 (ko) | 에르골린 에스테르의 제조방법 | |
| US2454747A (en) | Mixed alkyl esters of ascorbic acid | |
| FR2366311A1 (fr) | Procede pour la preparation de steroides polyhalogenes utiles comme medicaments | |
| US4053624A (en) | Indole-2-carbaldehyde compounds and blood sugar reducing compositions | |
| EP0017420A1 (en) | New dihydroxy-acylanthrones having anti-psoriatic activity, process for preparing them, pharmaceutical compositions comprising them, and their use as anti-psoriatic agents | |
| DE2532069A1 (de) | Acylierte pyrazofurinderivate und verfahren zu ihrer herstellung | |
| DE1445950B2 (de) | 2,6-bis-(hydroxymethyl)-pyridindicarbamat-derivate und verfahren zu ihrer herstellung | |
| FR2462444A1 (fr) | 25-halogeno-5-cholestene-3b, 22-diols et leurs esters utiles notamment comme hypocholesterolemiants | |
| JPS5830288B2 (ja) | シンキテルペノフエノ−ルノセイホウ | |
| GB2143814A (en) | Quinazolines | |
| FR2399417A1 (fr) | Nouveaux derives de la dibenzo (d,g) (1,3,6)dioxazocine, procedes de preparation de ces derives et medicaments contenant ceux-ci | |
| Pinza et al. | Convenient Synthesis of (RS)-4-Amino-3-hydroxybutyri Acid | |
| Nogrady | Potential Cytostatic Carbohydrate Derivatives. I. N-Mustard Urethans | |
| US4094988A (en) | Method of treating gastric ulcers using 5,6-dihydro-1,4-dithiinoxides | |
| US2655510A (en) | Water-soluble mono-betaine hydrazones of the aminochromes and process of preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: JOHNSON MATTHEY PUBLIC LTD CY Effective date: 19940930 |